Showing 38,381 - 38,400 results of 115,704 for search '(( a non decrease ) OR ( 5 ((wt decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.71s Refine Results
  1. 38381

    In Situ Methods for Identifying Reactive Surface Intermediates during Hydrogenolysis Reactions: C–O Bond Cleavage on Nanoparticles of Nickel and Nickel Phosphides by Megan E. Witzke (5489258)

    Published 2021
    “…Here, we identify distinct reactive intermediates, all of which exist at low coverages, that lead to distinguishable reaction pathways during the hydrogenolysis of 2-methyl­tetra­hydrofuran (MTHF) on Ni, Ni<sub>12</sub>P<sub>5</sub>, and Ni<sub>2</sub>P catalysts by combining advanced spectroscopic methods with quantum chemical calculations. …”
  2. 38382

    TEMPO-Oxidized Microcrystalline Cellulose for Rapid Adsorption of Ammonium by Jia Hui Ong (12085606)

    Published 2022
    “…Despite a slight decrease in adsorption performance, the material can be regenerated and applied in a real water sample. …”
  3. 38383

    Beware the Stick: A Case of a Fractured Nasopharyngeal COVID-19 Screening Swab Lost to a Patient’s Distal Airways by Karishma Chandarana (4607131)

    Published 2020
    “…The technique involved flexible bronchoscopy using a large (5.8 mm) Ambu® aScopeTM (AMBU® ASCOPETM 4 BRONCHO LARGE (5.8/2.8) with a 2.8 mm working port, via the existing size 7 tracheostomy tube with its inner tube removed. …”
  4. 38384
  5. 38385

    miR-<i>17-5p</i> expression is correlated to <i>MYCN</i> and <i>p21</i> levels in human primary neuroblastomas. by Laura Fontana (47437)

    Published 2008
    “…Group 3 (<i>lower panel</i>) includes <i>MYCN</i>-not-amplified tumors expressing high levels of miR-<i>17-5p</i> and moderately low levels of <i>p21</i> (a 40% decrease baseline is shown). …”
  6. 38386

    Data_Sheet_1_The association between diverse serum folate with MAFLD and liver fibrosis based on NHANES 2017–2020.xlsx by Jiacheng Cai (9322220)

    Published 2024
    “…As the concentrations of total folate and 5-MTHF in the serum increased, a substantial decrease in the likelihood of MAFLD and liver fibrosis occurrence was observed.…”
  7. 38387

    Image_1_Deletion of Kcnj16 in Mice Does Not Alter Auditory Function.TIF by Jun Lv (337346)

    Published 2021
    “…<p>Endolymphatic potential (EP) is the main driving force behind the sensory transduction of hearing, and K<sup>+</sup> is the main charge carrier. Kir5.1 is a K<sup>+</sup> transporter that plays a significant role in maintaining EP homeostasis, but the expression pattern and role of Kir5.1 (which is encoded by the Kcnj16 gene) in the mouse auditory system has remained unclear. …”
  8. 38388

    Image_2_Deletion of Kcnj16 in Mice Does Not Alter Auditory Function.TIF by Jun Lv (337346)

    Published 2021
    “…<p>Endolymphatic potential (EP) is the main driving force behind the sensory transduction of hearing, and K<sup>+</sup> is the main charge carrier. Kir5.1 is a K<sup>+</sup> transporter that plays a significant role in maintaining EP homeostasis, but the expression pattern and role of Kir5.1 (which is encoded by the Kcnj16 gene) in the mouse auditory system has remained unclear. …”
  9. 38389

    Image_3_Deletion of Kcnj16 in Mice Does Not Alter Auditory Function.TIF by Jun Lv (337346)

    Published 2021
    “…<p>Endolymphatic potential (EP) is the main driving force behind the sensory transduction of hearing, and K<sup>+</sup> is the main charge carrier. Kir5.1 is a K<sup>+</sup> transporter that plays a significant role in maintaining EP homeostasis, but the expression pattern and role of Kir5.1 (which is encoded by the Kcnj16 gene) in the mouse auditory system has remained unclear. …”
  10. 38390

    Image_4_Deletion of Kcnj16 in Mice Does Not Alter Auditory Function.TIF by Jun Lv (337346)

    Published 2021
    “…<p>Endolymphatic potential (EP) is the main driving force behind the sensory transduction of hearing, and K<sup>+</sup> is the main charge carrier. Kir5.1 is a K<sup>+</sup> transporter that plays a significant role in maintaining EP homeostasis, but the expression pattern and role of Kir5.1 (which is encoded by the Kcnj16 gene) in the mouse auditory system has remained unclear. …”
  11. 38391

    Table1_Kaempferol Inhibits Hepatic Stellate Cell Activation by Regulating miR-26b-5p/Jag1 Axis and Notch Pathway.DOCX by Guangyao Zhou (12704750)

    Published 2022
    “…In vitro, kaempferol enhanced the suppression of HSC activation, with a decrease in α-SMA as well as collagen level. …”
  12. 38392

    Table2_Kaempferol Inhibits Hepatic Stellate Cell Activation by Regulating miR-26b-5p/Jag1 Axis and Notch Pathway.DOCX by Guangyao Zhou (12704750)

    Published 2022
    “…In vitro, kaempferol enhanced the suppression of HSC activation, with a decrease in α-SMA as well as collagen level. …”
  13. 38393

    Transition probabilities phenotypes. by Jean-Baptiste Masson (107354)

    Published 2020
    “…</b> ratio of transition probabilities for selected hit lines relative to the control <b>B-G</b> Examples of transition probability phenotypes for hit lines of competitive interaction hits (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008589#pgen.1008589.g005" target="_blank">Fig 5</a>). …”
  14. 38394
  15. 38395
  16. 38396

    Compatibility of GROMOS-Derived Atomic Parameters for Lipopolysaccharide Membranes with the SPC/E Water Model and Alternative Long-Range Electrostatic Treatments Using Single Nonbo... by Manoela P. M. Lima (7528949)

    Published 2019
    “…The SPC/E model induces a small increase in OM fluidity, and when combined with the RF correction, shows a decrease in water orientation at the membrane surface. …”
  17. 38397

    Effects of Low-Fat, Mediterranean, or Low-Carbohydrate Weight Loss Diets on Serum Urate and Cardiometabolic Risk Factors - A Secondary Analysis of the Dietary Intervention Randomiz... by Chio Yokose (9221485)

    Published 2020
    “…SU reductions among those with hyperuricemia were 113, 119, and 143 μmol/L at 6 months for low-fat, Mediterranean, and low-carbohydrate diets (all p for within-group comparison <0.001; p>0.05 for between-group comparisons), and 65, 77, and 83 μmol/L, respectively, at 24-months (all p for within-group comparison <0.01; p>0.05 for between-group comparisons).</p> <a>Conclusions</a>: <a>Non-purine-focused weight loss diets may simultaneously improve SU and cardiovascular risk factors, likely mediated by reducing adiposity and insulin resistance. …”
  18. 38398

    Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels by Kyoko Fujita (257442)

    Published 2019
    “…Excretion rate of UA in the intestine was calculated using time course data. A decrease in UA excretion rate was observed in the intestine after administration of serum UA-lowering drugs (benzbromarone, febuxostat, and topiroxostat). …”
  19. 38399
  20. 38400